drugset / Trial / NCT01265342
Efficacy of Nebulised Beclometasone in Viral Wheezing Prophylaxis
Phase 4
Completed
576 enrolled
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco · collabAssociazione Culturale Pediatri · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Inhaled steroids, in particular beclomethasone, are widely prescribed in Italy as symptomatic treatment of upper respiratory infections without evidence of efficacy. The purpose of this study is to evaluate the efficacy of beclomethasone (administered by nebuliser twice a day) in preventing viral wheezing in pre-school children who had had episodes in the preceding 12 months.
Timeline
- Start
- 2010-10
- Primary completion
- 2012-03
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beclomethasone | Small molecule | 400 ug | — |